Genzyme (GENZ) Target Edged Higher to $73 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray raises the price target from $71 to $73 on Genzyme (Nasdaq: GENZ) citing greater
visibility on resolution of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
visibility on resolution of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
